Sean E. Aeder

Array ( [id] => 5034711 [patent_doc_number] => 20070099250 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-03 [patent_title] => 'Methods for treating proliferative diseases and for monitoring the effectiveness of treatment of proliferative diseases' [patent_app_type] => utility [patent_app_number] => 10/553091 [patent_app_country] => US [patent_app_date] => 2004-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8840 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20070099250.pdf [firstpage_image] =>[orig_patent_app_number] => 10553091 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7673377 [patent_doc_number] => 20040180402 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-16 [patent_title] => 'Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof' [patent_app_type] => new [patent_app_number] => 10/473738 [patent_app_country] => US [patent_app_date] => 2004-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 21214 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20040180402.pdf [firstpage_image] =>[orig_patent_app_number] => 10473738 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7238421 [patent_doc_number] => 20040157788 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-12 [patent_title] => 'High affinity antibodies' [patent_app_type] => new [patent_app_number] => 10/451302 [patent_app_country] => US [patent_app_date] => 2004-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2546 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20040157788.pdf [firstpage_image] =>[orig_patent_app_number] => 10451302 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5095555 [patent_doc_number] => 20070117164 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-24 [patent_title] => 'Method for detection of colorectal cancer in human samples' [patent_app_type] => utility [patent_app_number] => 10/552656 [patent_app_country] => US [patent_app_date] => 2004-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 26199 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20070117164.pdf [firstpage_image] =>[orig_patent_app_number] => 10552656 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7018777 [patent_doc_number] => 20050220796 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-06 [patent_title] => 'Compositions and methods for modulating DNA repair' [patent_app_type] => utility [patent_app_number] => 10/813977 [patent_app_country] => US [patent_app_date] => 2004-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 18506 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20050220796.pdf [firstpage_image] =>[orig_patent_app_number] => 10813977 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7341102 [patent_doc_number] => 20040191169 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-30 [patent_title] => 'Methods of protection from toxicity of alpha emitting elements during radioimmunotherapy' [patent_app_type] => new [patent_app_number] => 10/806905 [patent_app_country] => US [patent_app_date] => 2004-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9498 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20040191169.pdf [firstpage_image] =>[orig_patent_app_number] => 10806905 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5672985 [patent_doc_number] => 20060178340 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-10 [patent_title] => 'Composition comprising soluble glucan oligomer from saccharomyces cerevisiae is2 for immune activation or prevention and treatment of cancer and the preparation method thereof' [patent_app_type] => utility [patent_app_number] => 10/549016 [patent_app_country] => US [patent_app_date] => 2004-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5676 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0178/20060178340.pdf [firstpage_image] =>[orig_patent_app_number] => 10549016 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4443855 [patent_doc_number] => 07862816 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-01-04 [patent_title] => 'Polypeptide compounds for inhibiting angiogenesis and tumor growth' [patent_app_type] => utility [patent_app_number] => 10/800350 [patent_app_country] => US [patent_app_date] => 2004-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 105 [patent_figures_cnt] => 129 [patent_no_of_words] => 40846 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/862/07862816.pdf [firstpage_image] =>[orig_patent_app_number] => 10800350 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 820432 [patent_doc_number] => 07407762 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-08-05 [patent_title] => 'Diagnosis of gynecological neoplasms by detecting the levels of oviduct-specific glycoprotein' [patent_app_type] => utility [patent_app_number] => 10/548580 [patent_app_country] => US [patent_app_date] => 2004-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8456 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/407/07407762.pdf [firstpage_image] =>[orig_patent_app_number] => 10548580 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6931135 [patent_doc_number] => 20050282170 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-22 [patent_title] => 'Method to detect prostate cancer in a sample' [patent_app_type] => utility [patent_app_number] => 10/773440 [patent_app_country] => US [patent_app_date] => 2004-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 16626 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0282/20050282170.pdf [firstpage_image] =>[orig_patent_app_number] => 10773440 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7264762 [patent_doc_number] => 20040151717 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-05 [patent_title] => 'Use of polyclonal immunoglobulins' [patent_app_type] => new [patent_app_number] => 10/478942 [patent_app_country] => US [patent_app_date] => 2004-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3997 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0151/20040151717.pdf [firstpage_image] =>[orig_patent_app_number] => 10478942 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 404554 [patent_doc_number] => 07288383 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-10-30 [patent_title] => 'Eosinophil-derived neurotoxin as a marker for ovarian cancer' [patent_app_type] => utility [patent_app_number] => 10/755854 [patent_app_country] => US [patent_app_date] => 2004-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 7332 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/288/07288383.pdf [firstpage_image] =>[orig_patent_app_number] => 10755854 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5808295 [patent_doc_number] => 20060094650 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-04 [patent_title] => 'Agent for improving life expectancy in therapy of malignant tumor' [patent_app_type] => utility [patent_app_number] => 10/540852 [patent_app_country] => US [patent_app_date] => 2003-12-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3982 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20060094650.pdf [firstpage_image] =>[orig_patent_app_number] => 10540852 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7275620 [patent_doc_number] => 20040235071 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-25 [patent_title] => 'Methods and compositions for treating cancer using 15986, 2188, 20743, 9148, 9151, 9791, 44252, 14184, 42461, 8204, 7970, 25552, 21657, 26492, 2411, 15088, 1905, 28899, 63380, 33935, 10480, 12686, 25501, 17694, 15701, 53062, 49908, 21612, 38949, 6216, 46863, 9235, 2201, 6985, 9883, 12238, 18057, 21617, 39228, 49928, 54476, 62113, 64316, 12264, 32362, 58198, 2887, 3205, 8557, 9600, 9693, 44867, 53058, 55556, 57658, 2208, 10252, 10302, 14218, 33877, 10317, 10485, 25964, 14815, 1363, 1397, 14827, 21708, 3801, 64698, 2179 or 13249' [patent_app_type] => new [patent_app_number] => 10/737450 [patent_app_country] => US [patent_app_date] => 2003-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 105487 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 144 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20040235071.pdf [firstpage_image] =>[orig_patent_app_number] => 10737450 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 645657 [patent_doc_number] => 07119174 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-10-10 [patent_title] => 'Diagnosis and treatment of AUR1 and/or AUR2 related disorders' [patent_app_type] => utility [patent_app_number] => 10/734126 [patent_app_country] => US [patent_app_date] => 2003-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 28333 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/119/07119174.pdf [firstpage_image] =>[orig_patent_app_number] => 10734126 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5808294 [patent_doc_number] => 20060094649 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-04 [patent_title] => 'Hla-a1,-a2,-a3,-a24,-b7, and-b44 tumor associated antigen peptides and compositions' [patent_app_type] => utility [patent_app_number] => 10/538066 [patent_app_country] => US [patent_app_date] => 2003-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 76361 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20060094649.pdf [firstpage_image] =>[orig_patent_app_number] => 10538066 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5912340 [patent_doc_number] => 20060127402 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-15 [patent_title] => 'Pharmaceutical compositions and methods useful for modulating angiogenesis, inhibiting metastasis and tumor fibrosis, and assessing the malignancy of colon cancer tumors' [patent_app_type] => utility [patent_app_number] => 10/536440 [patent_app_country] => US [patent_app_date] => 2003-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 24922 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0127/20060127402.pdf [firstpage_image] =>[orig_patent_app_number] => 10536440 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5852016 [patent_doc_number] => 20060235207 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-19 [patent_title] => 'Antibodies against lesion tissue' [patent_app_type] => utility [patent_app_number] => 10/535764 [patent_app_country] => US [patent_app_date] => 2003-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 10338 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20060235207.pdf [firstpage_image] =>[orig_patent_app_number] => 10535764 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7468947 [patent_doc_number] => 20040102383 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-27 [patent_title] => 'Growth inhibition and eradication of solid tumors using neuroendocrine resetting therapy and photodynamic therapy' [patent_app_type] => new [patent_app_number] => 10/719534 [patent_app_country] => US [patent_app_date] => 2003-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11456 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 148 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0102/20040102383.pdf [firstpage_image] =>[orig_patent_app_number] => 10719534 [rel_patent_id] =>[rel_patent_doc_number] =>)